NICE guidelines on Prostate Cancer Active Surveillance: is UK practice leading the world?-Reference-Cited by-同舟云学术

NICE guidelines on Prostate Cancer Active Surveillance: is UK practice leading the world?

Published:2014-10-18 Issue:1 Volume:115 Page:12-13
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Streeter Edward H.¹,Brewster Simon F.²,

Affiliation:

1. Department of Urology; Kent and Canterbury Hospital; Canterbury Kent UK

2. Department of Urology; Churchill Hospital; Oxford Oxfordshire UK

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12752/fullpdf

Reference8 articles.

1. NICE National Collaborating Centre for Cancer. Prostate Cancer: Diagnosis and Treatment. Clinical Guideline http://www.nice.org.uk/nicemedia/live/14348/66232/66232.pdf

2. PRIAS Active Surveillance of Early Prostate Cancer http://www.prias-project.org

3. EAU Guidelines on Prostate Cancer http://www.uroweb.org/gls/pdf/09%20Prostate%20Cancer_LRLV2.pdf

4. Active surveillance in a UK cancer Centre - are patients being put at risk?;Streeter;BJUI Int,2012

5. Medium-term outcomes of active surveillance for localised prostate cancer;Selvadurai;Eur Urol,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serial prostate magnetic resonance imaging fails to prelict pathological progression in patients on active surveillance;CUAJ-CAN UROL ASSOC;2022

2. Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis;BJU International;2019-04-25

3. National Private Payer Coverage of Prostate MRI;Journal of the American College of Radiology;2019-01

4. MRI in active surveillance: a critical review;Prostate Cancer and Prostatic Diseases;2018-08-16

5. Nurse-led active surveillance for prostate cancer is safe, effective and associated with high rates of patient satisfaction—results of an audit in the East of England;ecancermedicalscience;2018-07-25